Comparative trial evaluates cellular uptake of donepezil-loaded nanoparticles in Alzheimer's disease, suggesting an impact of nanocarrier composition.
Donepezil-loaded PCL/PVA nanoparticles and DPPC liposomes exhibited nanoscale dimensions and a safe profile. Polymeric nanoparticles exhibited greater cellular uptake, highlighting the influence of nanocarrier composition on cell-nanoparticle interactions.
No takes yet. Share an insight, caveat, or question.
Torossian et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: